Table 1 Laboratory studies of the clinical case.

From: Observation of PICALM::MLLT10-rearrangement and coincidental EZH2 mutations in a patient with acute myeloid leukemia: A case report and review of the literature

Parameter, Unit

Value

Reference

CBC

Hemoglobin, g/l

118

135–168

Hematocrit, l/l

0.34

0.40–0.50

Thrombocytes, G/l

24

150–450

Leukocytes, G/l

5.84

3.0–10.5

Blasts, G/l

2.66

0.00

Blasts, %

45.5

0

Neutrophils, G/l

0.41

1.60–7.40

Band forms, G/l

0.09

0.20–1.40

Eosinophils, G/l

0.06

0.02–0.40

Basophils, G/l

0.00

0.00–0.15

Monocytes, G/l

0.00

0.20–0.93

Lymphocytes, G/l

1.49

1.10–3.50

Coagulation Studies

aPTT, sec.

49.2

25.1–36.5

PT, %

41

70–120

Fibrinogen, g/l

3.36

2.00–3.93

D-Dimer, µg/l

>80.000

<500

Clinical Chemistry

LDH, U/l

6553

125–220

CRP, mg/l

495

0–5

CK, U/l

502

30–200

  1. Values outside their respective reference ranges are bold.
Back to article page